Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
glucagon-like peptide 1 microneedle patch
- Development stage
- Unknown
- Lead developer
- Daewoong Therapeutics
- Modality
- Peptides
- Administration
- Transdermal
01
Overview
Gylden Pharma's GLP-1 microneedle patch is an investigational transdermal therapy currently in Phase 1 development for the treatment of type 2 diabetes and obesity. Utilizing Gylden Pharma's proprietary Gylden Patch technology, the system is designed to provide a painless, self-administered alternative to traditional subcutaneous injections of glucagon-like peptide 1 (GLP-1) receptor agonists. The patch consists of an array of microscopic needles that penetrate the stratum corneum to deliver the GLP-1 peptide directly into the underlying dermis. This delivery modality aims to improve patient compliance and provide stable therapeutic levels of the hormone, which plays a critical role in regulating glucose metabolism and appetite.
- Other names
- GLP-1 microneedle patchGLP1 microneedle patchGLP 1 microneedle patchGylden Pharma GLP-1 patchGylden Patch GLP-1
02
Targets
Beyond the preview
Go deeper on glucagon-like peptide 1 microneedle patch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on glucagon-like peptide 1 microneedle patch.